Complement Protein Isoforms in CSF as Possible Biomarkers for Neurodegenerative Disease
It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor...
Saved in:
Published in | Disease markers Vol. 21; no. 2; pp. 93 - 101 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
IOS Press
01.01.2005
|
Subjects | |
Online Access | Get full text |
ISSN | 0278-0240 1875-8630 |
DOI | 10.1155/2005/806573 |
Cover
Abstract | It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor B, and factor H were compared between normal subjects and patients diagnosed with AD, PD, MS, and neurosyphilis. The CSF proteins were initially separated using two‐dimensional gel electrophoresis, which allowed the comparison of some of the individual complement isoforms. Patients with AD, PD, and MS all showed more than one complement isoform with a significant change (
p
< 0.05) in CSF expression level compared to normal
subjects. PD patients were found to have the greatest number of significantly changed isoforms, all showing a decreased expression
level in PD CSF. The complement isoforms examined were able to distinguish between some, but not all, of the diseases
studied. The data suggest that when investigating a protein as a possible biomarker, it may be useful to compare individual protein
isoform expression levels in addition to the more commonly measured total protein expression level. |
---|---|
AbstractList | It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor B, and factor H were compared between normal subjects and patients diagnosed with AD, PD, MS, and neurosyphilis. The CSF proteins were initially separated using two‐dimensional gel electrophoresis, which allowed the comparison of some of the individual complement isoforms. Patients with AD, PD, and MS all showed more than one complement isoform with a significant change (
p
< 0.05) in CSF expression level compared to normal
subjects. PD patients were found to have the greatest number of significantly changed isoforms, all showing a decreased expression
level in PD CSF. The complement isoforms examined were able to distinguish between some, but not all, of the diseases
studied. The data suggest that when investigating a protein as a possible biomarker, it may be useful to compare individual protein
isoform expression levels in addition to the more commonly measured total protein expression level. It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor B, and factor H were compared between normal subjects and patients diagnosed with AD, PD, MS, and neurosyphilis. The CSF proteins were initially separated using two-dimensional gel electrophoresis, which allowed the comparison of some of the individual complement isoforms. Patients with AD, PD, and MS all showed more than one complement isoform with a significant change (p < 0.05) in CSF expression level compared to normal subjects. PD patients were found to have the greatest number of significantly changed isoforms, all showing a decreased expression level in PD CSF. The complement isoforms examined were able to distinguish between some, but not all, of the diseases studied. The data suggest that when investigating a protein as a possible biomarker, it may be useful to compare individual protein isoform expression levels in addition to the more commonly measured total protein expression level.It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor B, and factor H were compared between normal subjects and patients diagnosed with AD, PD, MS, and neurosyphilis. The CSF proteins were initially separated using two-dimensional gel electrophoresis, which allowed the comparison of some of the individual complement isoforms. Patients with AD, PD, and MS all showed more than one complement isoform with a significant change (p < 0.05) in CSF expression level compared to normal subjects. PD patients were found to have the greatest number of significantly changed isoforms, all showing a decreased expression level in PD CSF. The complement isoforms examined were able to distinguish between some, but not all, of the diseases studied. The data suggest that when investigating a protein as a possible biomarker, it may be useful to compare individual protein isoform expression levels in addition to the more commonly measured total protein expression level. It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Here, the CSF expression levels of complement proteins C3b, C4b, factor B, and factor H were compared between normal subjects and patients diagnosed with AD, PD, MS, and neurosyphilis. The CSF proteins were initially separated using two-dimensional gel electrophoresis, which allowed the comparison of some of the individual complement isoforms. Patients with AD, PD, and MS all showed more than one complement isoform with a significant change (p < 0.05) in CSF expression level compared to normal subjects. PD patients were found to have the greatest number of significantly changed isoforms, all showing a decreased expression level in PD CSF. The complement isoforms examined were able to distinguish between some, but not all, of the diseases studied. The data suggest that when investigating a protein as a possible biomarker, it may be useful to compare individual protein isoform expression levels in addition to the more commonly measured total protein expression level. |
Author | Finehout, Erin J. Franck, Zsofia Lee, Kelvin H. |
AuthorAffiliation | School of Chemical and Biomolecular Engineering Cornell University Ithaca NY 14853 USA |
AuthorAffiliation_xml | – name: School of Chemical and Biomolecular Engineering Cornell University Ithaca NY 14853 USA |
Author_xml | – sequence: 1 givenname: Erin J. surname: Finehout fullname: Finehout, Erin J. – sequence: 2 givenname: Zsofia surname: Franck fullname: Franck, Zsofia – sequence: 3 givenname: Kelvin H. surname: Lee fullname: Lee, Kelvin H. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15920296$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1P3DAQxS0EgmXbU--VT1yqwDi2E_uCRJdPCdGVoOrRcpIJdUnixc4i8d_j1VIoFRIn25qfn968t0s2Bz8gIV8Y7DMm5UEOIA8UFLLkG2TCVCkzVXDYJBPIS5VBLmCH7Mb4B4DlWuhtssOkziHXxYT8mvl-0WGPw0jnwY_oBnoRfetDH2m6z65PqY107mN0VYf0u_O9DXcYIk0MvcJl8A3e4oDBju4B6bGLaCN-Ilut7SJ-fj6n5Ofpyc3sPLv8cXYxO7rMasFgzKRouQAQZa2LSirFrVJaCAXpWWBlRVULWwK3orEVB14VeaOV1kpJ0bRa8Sk5XOsullWPTZ32CLYzi-CSzUfjrTNvJ4P7bW79g-FKMlA6Cew9CwR_v8Q4mt7FGrvODuiX0RSlKrnQ5Ycg01xwKSCBX_-19OLlb-gJ-LYG6pBiDdi-ImBWlZpVpWZdaaLZf3TtxpS1X-3junf_PAEMXKKQ |
CitedBy_id | crossref_primary_10_1586_epr_09_91 crossref_primary_10_1093_brain_awq085 crossref_primary_10_1002_jcb_23204 crossref_primary_10_1016_j_nbd_2010_04_020 crossref_primary_10_1016_j_jprot_2010_11_010 crossref_primary_10_1002_prca_200900065 crossref_primary_10_1186_s12974_021_02225_9 crossref_primary_10_3390_md20010018 crossref_primary_10_1179_1743132815Y_0000000075 crossref_primary_10_1007_s00702_012_0797_8 crossref_primary_10_1111_j_1471_4159_2009_06558_x crossref_primary_10_1016_j_hoc_2015_06_006 crossref_primary_10_3389_fncel_2014_00380 crossref_primary_10_1111_j_1600_0404_2007_00985_x crossref_primary_10_1093_brain_awl279 crossref_primary_10_1111_j_1365_2249_2008_03830_x crossref_primary_10_1586_epr_10_75 crossref_primary_10_1007_s00702_008_0070_3 crossref_primary_10_1016_j_jprot_2010_01_004 crossref_primary_10_1016_j_euprot_2014_02_003 crossref_primary_10_1021_pr070220c crossref_primary_10_1016_j_bbrc_2006_02_051 crossref_primary_10_1002_jcb_23113 crossref_primary_10_1016_j_imbio_2011_07_023 crossref_primary_10_1038_s41536_023_00311_5 crossref_primary_10_1586_14789450_3_1_45 crossref_primary_10_3389_fneur_2024_1360222 crossref_primary_10_3389_fgene_2022_892491 crossref_primary_10_1186_1750_1326_9_22 crossref_primary_10_1111_ner_13075 crossref_primary_10_1186_s13195_023_01377_5 crossref_primary_10_1371_journal_pone_0016032 crossref_primary_10_3233_JAD_231235 crossref_primary_10_1007_s00702_018_1857_5 crossref_primary_10_1186_alzrt266 crossref_primary_10_1016_j_jprot_2011_05_042 crossref_primary_10_1002_pmic_200600284 crossref_primary_10_1007_s00702_017_1792_x crossref_primary_10_3389_fncel_2023_1094106 crossref_primary_10_3390_brainsci11111515 crossref_primary_10_1007_s12035_013_8519_2 crossref_primary_10_1016_j_ajpath_2011_01_006 crossref_primary_10_1186_s12903_023_03846_7 crossref_primary_10_1007_s11064_008_9588_x crossref_primary_10_1586_14789450_5_1_1 crossref_primary_10_3389_fncel_2014_00369 crossref_primary_10_2139_ssrn_4118345 crossref_primary_10_3233_JAD_180833 crossref_primary_10_1002_pmic_201500167 crossref_primary_10_1007_s10571_019_00700_9 crossref_primary_10_1016_j_jprot_2013_01_025 crossref_primary_10_1016_j_nurx_2006_05_001 crossref_primary_10_3389_fimmu_2022_1055050 crossref_primary_10_1586_14789450_4_2_227 crossref_primary_10_12688_f1000research_6801_2 crossref_primary_10_1186_s13195_020_00628_z crossref_primary_10_12688_f1000research_6801_1 crossref_primary_10_1042_CS20230513 crossref_primary_10_1002_elps_201300609 crossref_primary_10_1093_brain_awaa425 crossref_primary_10_3233_JAD_151075 crossref_primary_10_3892_ijmm_2013_1267 crossref_primary_10_1002_prca_200800251 crossref_primary_10_1016_j_parkreldis_2008_05_014 crossref_primary_10_1586_14737159_7_5_635 crossref_primary_10_1007_s40291_013_0069_9 |
ContentType | Journal Article |
Copyright | Copyright © 2005 Hindawi Publishing Corporation. 2005 |
Copyright_xml | – notice: Copyright © 2005 Hindawi Publishing Corporation. 2005 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7X8 5PM |
DOI | 10.1155/2005/806573 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1875-8630 |
EndPage | 101 |
ExternalDocumentID | PMC3851089 15920296 10_1155_2005_806573 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R01MH59926 |
GroupedDBID | --- .GJ 0R~ 24P 29G 36B 4.4 53G 5GY 5RE 5VS AAFNC AAFWJ AAJEY AAYXX ABJNI ABUBZ ACCMX ACGFS ACIWK ACPQW ACPRK ADBBV ADRAZ ADZMO AENEX AFRAH AFRHK AGIAB ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CAG CITATION COF DIK DU5 EBS EJD EMB F5P H13 HYE HZ~ IHR IL9 INR IOS IPNFZ KQ8 M48 MET MIO O9- OK1 P2P RIG RNS RPM ZGI AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 7X8 5PM |
ID | FETCH-LOGICAL-c410t-54f340047c96b5883a889448096b6eba4bc4a703a4dab303b62d98998854df983 |
IEDL.DBID | M48 |
ISSN | 0278-0240 |
IngestDate | Thu Aug 21 18:01:51 EDT 2025 Fri Sep 05 04:15:02 EDT 2025 Thu Sep 04 20:08:43 EDT 2025 Mon Jul 21 05:59:23 EDT 2025 Tue Jul 01 04:22:06 EDT 2025 Thu Apr 24 22:55:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c410t-54f340047c96b5883a889448096b6eba4bc4a703a4dab303b62d98998854df983 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2005/806573 |
PMID | 15920296 |
PQID | 19343540 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3851089 proquest_miscellaneous_67873497 proquest_miscellaneous_19343540 pubmed_primary_15920296 crossref_primary_10_1155_2005_806573 crossref_citationtrail_10_1155_2005_806573 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-01-00 2005-00-00 20050101 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – month: 01 year: 2005 text: 2005-01-00 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Disease markers |
PublicationTitleAlternate | Dis Markers |
PublicationYear | 2005 |
Publisher | IOS Press |
Publisher_xml | – name: IOS Press |
SSID | ssj0012949 |
Score | 1.9870707 |
Snippet | It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer’s... It has been suggested that the activation of the complement system is involved in the pathogenesis of several neurodegenerative diseases including Alzheimer's... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 93 |
SubjectTerms | Alzheimer Disease - cerebrospinal fluid Biomarkers Complement C3b - cerebrospinal fluid Complement C4b - cerebrospinal fluid Complement Factor B - cerebrospinal fluid Complement Factor H - cerebrospinal fluid Complement System Proteins - cerebrospinal fluid Electrophoresis, Gel, Two-Dimensional Humans Mass Spectrometry Multiple Sclerosis - cerebrospinal fluid Neurodegenerative Diseases - cerebrospinal fluid Neurodegenerative Diseases - diagnosis Other Parkinson Disease - cerebrospinal fluid |
Title | Complement Protein Isoforms in CSF as Possible Biomarkers for Neurodegenerative Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15920296 https://www.proquest.com/docview/19343540 https://www.proquest.com/docview/67873497 https://pubmed.ncbi.nlm.nih.gov/PMC3851089 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dT9swED-1IE17QXzso3wUP_A0KSNz7MR-QGgrqxioE9NWrW9RHLujUkmgaSX477lLUrp2IO0tUs5K5PP5fuc7_w7gKBVBZCPuvAR3Pk_QHV2Nivas8IfWKWGGjm4j976H531xMZCDBsybcdYTWDwb2lE_qf5k_PH-7uEUDf6kNHgpj-lg5JgShFHQhHV0SSFFYT2xSCdwXeFgTnSy6MPqi3org5dd0z94c7Vs8i8_1N2EjRpAss-Vxreg4bJteNWrU-Q78JssvKoJZ1dEwjDK2LciJ2xaMHzu_OyypGBXORnD2LEvo_yGSnQmBUMZVpJ1WPenZKOmrZCdVSmcN9Dvfv3VOffq7gleKj75U0-KYUAGGqU6NFKpIFFKYzCGMYsJnUmESUWC9p4Imxh0ZCbkVlP0paSwQ62Ct7CW5Zl7D0wGKSITJS3iBSEtN5o7P7WcRhBlVgs-zCcuTmtqcepwMY7LEENKanYp42qWW7hA5sK3FaPG82KHcw3EuOIpjZFkLp8VMUJOQadVL0ugA44CoaMWvKs0tviQ1NznOmxBtKTLJwFi215-k42uS9btALGpr_Tu__3-HrwuSV7Lw5p9WJtOZu4A4cvUtKF5-UO1ywX6CBXN68U |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complement+protein+isoforms+in+CSF+as+possible+biomarkers+for+neurodegenerative+disease&rft.jtitle=Disease+markers&rft.au=Finehout%2C+Erin+J&rft.au=Franck%2C+Zsofia&rft.au=Lee%2C+Kelvin+H&rft.date=2005&rft.issn=0278-0240&rft.volume=21&rft.issue=2&rft.spage=93&rft_id=info:doi/10.1155%2F2005%2F806573&rft_id=info%3Apmid%2F15920296&rft.externalDocID=15920296 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-0240&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-0240&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-0240&client=summon |